HR2592Referred to Committee

Aviation Medication Transparency Act of 2025

Share:
Introduced
In Committee
3
Passed One Chamber
4
Passed Both
5
Signed into Law
119th
Congress
2025-04-02
Introduced
25
Cosponsors
HR
ⓘ
Type

Sponsor

Sean Casten
Sean Casten
Democrat · IL · Representative
Votes with party: 98.2% (667 recorded votes)

Full profile: /officials/C001117

Source: Congress.gov · FEC

Cosponsors (25)

Members who have signed on to support this bill since introduction. Source: Congress.gov.

Latest Action

The most recent step in the bill's legislative path. Committee Activity below shows referrals and reports; the full action-by-action history including floor proceedings lives at Congress.gov →

Ordered to be Reported (Amended) by Voice Vote.

2026-09-15

Source: Congress.gov

Committee Activity

Currently in

Previously

Plain-English Summary

Aviation Medication Transparency Act of 2025 This bill directs the Federal Aviation Administration (FAA) to compile, publish, and annually update a list of medications that may be safely prescribed to pilots and air traffic controllers for the purposes of issuing a medical certification. The list must be publicly available on the FAA website and distributed to those seeking a license and medical certification. Currently, the FAA does not have a list of approved medications. However, the FAA does have lists for Aviation Medical Examiners of Do Not Issue medications and Do Not Fly medications.

Plain-English rewrite of the Congressional Research Service summary published on Congress.gov. Cached and reviewed.

Subjects

Transportation and Public Works

Full Bill Text

Verbatim text published on Congress.gov via GovInfo. Use Cmd+F / Ctrl+F to search within this excerpt.

[Congressional Bills 119th Congress] [From the U.S. Government Publishing Office] [H.R. 2592 Introduced in House (IH)] <DOC> 119th CONGRESS 1st Session H. R. 2592 To require the Administrator of the Federal Aviation Administration to publish the list of medications that the Administrator has compiled for purposes of the medical certification of airmen, and for other purposes. _______________________________________________________________________ IN THE HOUSE OF REPRESENTATIVES April 2, 2025 Mr. Casten (for himself and Mr. Stauber) introduced the following bill; which was referred to the Committee on Transportation and Infrastructure _______________________________________________________________________ A BILL To require the Administrator of the Federal Aviation Administration to publish the list of medications that the Administrator has compiled for purposes of the medical certification of airmen, and for other purposes. Be it enacted by the Senate and House of Representatives of the United States of America in Congress assembled, SECTION 1. SHORT TITLE. This Act may be cited as the ``Aviation Medication Transparency Act of 2025''. SEC. 2. LIST OF APPROVED MEDICATIONS. (a) In General.--Not later than 1 year after the date of enactment of this Act, the Administrator of the Federal Aviation Administration shall publish and maintain on a publicly available website of the Administration the list of medications and treatments that may be safely prescribed to an airman to treat certain medical conditions that the Administrator has compiled for purposes of the issuance of a medical certification to an airman. (b) Requirements.--The list required under subsection (a) shall-- (1) be drafted in consultation with-- (A) the Aeromedical Innovation and Modernization Working Group; (B) the certified exclusive bargaining representatives of air traffic controllers of the Administration certified under section 7111 of title 5, United States Code; (C) the principal organization representing the largest certified collective bargaining representative of airline pilots; and (D) any other stakeholder determined relevant by the task group, including any stakeholders described in section 411(d)(3)(B) of the FAA Reauthorization Act of 2024; (2) be comprehensive; (3) be drafted in a user-friendly and accessible manner and provided to airmen at the time when such airmen first seek a license and medical certification; (4) indicate what, if any, period of time, on average, an airman must have limited or no duties to stabilize on an approved medication; (5) include the list of medications that the Administrator has designated as ``Do Not Issue''; (6) include a mechanism for doctors or medical providers to contact the Federal Aviation Administration regarding questions related to such list; (7) include any additional information that the Administrator determines is appropriate to provide with respect to what conditions a certain medication may or may not be used to treat and any information to explain why a medication is allowed or prohibited by the Federal Aviation Administration; and (8) include any other information or clarification that the Administrator determines appropriate. (c) Annual Update.--Not later than 1 year after the date of publication of the list required under subsection (a), and annually thereafter, the Administrator shall update such list, as appropriate. <all>
Open clean-text viewRead on Congress.gov →

Related legislation

Bills by the same sponsor or covering overlapping subjects.